Coherent, preventive and management strategies for obesity

CIBA Foundation Symposia

Volumn , Issue 201, 1996, Pages 228-254

  Bray, George A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; OBESITY; REVIEW; RISK FACTOR;

HUMANS; OBESITY; RISK FACTORS;

EID: 0030340623     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Andersen T, Astrup A, Quaade F 1992 Dexfenfluramine as adjuvant to low-calorie formula diet in the treatment of obesity: a randomized clinical trial. Int J Obes 16:35-40
2. Arch JRS, Kaumann AJ 1993 Beta (3)-adrenoceptor and atypical beta-adrenoceptor. Med Res Rev 13:663-729
3. Ashley FW, Kannel WB 1974 Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis 27:103-114
4. Atkinson RL, Dietz WH, Foreyt JP et al 1994 Weight cycling. JAMA 272:1196-1202
5. Ballor DL, Keesey RE 1991 A meta-analysis of the factors affecting exercise-induced changes in body mass, fat mass and fat-free mass in males and females. Int J Obes 15:717-726
6. Banting W 1864 Letter on corpulence, addressed to the public, 3rd edn. Harrison, London
7. Blackburn GL, Kanders BS 1994 Obesity. Pathophysiology, psychology and treatment. Chapman & Hall, New York
8. Blair SN, Kohl HW, Barlow CE et al 1995 Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 273:1093-1098
9. Bouchard C (ed) 1994 The genetics of obesity. CRC Press, Boca Raton, FL
10. Bouchard C, Pérusse L 1996 Current status of the human obesity gene map. Obesity Res 4:80-89
11. Bray GA 1990 Obesity: historical development of scientific and cultural ideas. Int J Obes 14:909-926
12. Bray GA 1994 Topography of body fat. Adv Endocrinol Metab 5:297-322
13. Bray GA 1995a Pharmacologic treatment of obesity: symposium overview. Obesity Res 3:415S-417S
14. Bray GA 1995b Evaluation of drugs for treating obesity. Obesity Res 3:425S-434S
15. Bray GA, Gray DS 1988a Obesity, part I: Pathogenesis. West J Med 149:429-441
16. Bray GA, Gray DS 1988b Obesity, part II: Treatment. West J Med 149:555-571
17. Bray GA, Ryan DH, Gordon D, Heidingsfelder H, Cerise F, Wilson K 1996 A double-blind randomized placebo-controlled trial of sibutramine. Obesity Res 4:263-270
18. Brownell KD, Kramer FM 1989 Behavioral management of obesity. Med Clin North Am 73:185-201
19. Colditz GA 1992 Economic costs of obesity. Am J Clin Nutr 55:503S-507S
20. Darga LL, Carroll-Michals L, Botsford SJ, Lucas CP 1991 Fluoxetine's effect on weight loss in obese subjects 1-3. Am J Clin Nutr 54:321-325
21. Drent ML, Larsson I, William-Olsson T et al 1995 Orlistat (RO-18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes 19:221-226
22. Elmer PJ, Grimm R, Laing B et al 1995 Life-style intervention: results of the treatment of mild hypertension study (TOMHS). Prev Med 24:378-388
23. Epstein LH, Valoski A, Wing RR, McCurley J 1990 Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 264:2519-2523
24. Gray DS, Fujioka K, Devine W, Bray GA 1992 Fluoxetine treatment of the obese diabetic. Int J Obes 16:193-198
25. Griffiths M, Payne PR, Stunkard AJ, Rivers JPW, Cox M 1990 Metabolic-rate and physical development in children at risk of obesity. Lancet 336:76-78
26. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P 1989 International trial of long-term dexfenfluramine in obesity. Lancet II:1142-1144
27. Hansen BC, Bodkin NL 1993 Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 42:1809-1814
28. Hypertension Prevention Trial Research Group 1990 The hypertension prevention trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 150:153-162
29. Jolliffe NJ 1963 Reduce and stay reduced on the prudent diet, 3rd edn. Simon & Schuster, New York
30. Kannel WB, Gordon T 1979 Physiological and medical concomittants of obesity: the Framingham study. In: Bray GA (ed) Obesity in America. Department of Health, Education and Welfare, Washington, DC, p 125-153
31. Klesges RC, Benowitz NL, Meyers AW 1991 Behavioral and biobehavioral aspects of smoking and smoking cessation: the problem of postcessation weight gain. Behav Ther 22:179-199
32. Korkeila M, Kaprio J, Pissanen A, Koskenvuo M 1995 Consistency and change of body mass index and weight: a study on 5967 adult Finnish twin pairs. Int J Obes 19:310-317
33. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL 1994 Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272:205-211
34. Lawson OJ, Williamson DA, Champagne CM et al 1995 The association of body weight, dietary intake, and energy expenditure with dietary restraint and disinhibition. Obesity Res 3:153-161
35. Lew EA, Garfinkel L 1979 Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32:563-576
36. Lindsted K, Tonstad S, Kuzma JW 1991 Body mass index and patterns of mortality among Seventh-day Adventist men. Int J Obes 15:397-406
37. Lissau I, Sorensen TIA 1994 Parental neglect during childhood and increased risk of obesity in young adulthood. Lancet 343:324-327
38. Lissner L, Heitmann BL 1995 Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 49:79-90
39. Long SD, O'Brien K, Macdonald KG Jr et al 1994 Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. Diabetes Care 17:372-375
40. Manson JE, Stampfer MJ, Hennekens CH, Willett WC 1987 Body weight and longevity. A reassessment. JAMA 257:353-358
41. Manson JE, Willett WC, Stampfer MJ et al 1995 Body weight and mortality among women. N Engl J Med 333:677-685
42. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W 1990 A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 147:876-881
43. Masoro EJ 1985 Aging and nutrition: can diet affect life span? Trans Assoc Life Insur Med Dir Am 67:30-44
44. Munro JF, MacCuish AC, Wilson EM, Duncan LJP 1968 Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J 1:352-354
45. Ohlson LO, Larsson B, Eriksson H, Svärdsudd K, Welin L, Tibblin G 1987 Diabetes mellitus in Swedish middle-aged men: the study of men born in 1913 and 1923. Diabetologia 30:386-393
46. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB 1993 The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 328:538-545
47. Pamuk ER, Williamson DF, Madans J, Serdula MK, Kleinman JC, Byers T 1992 Weight-loss and mortality in a national cohort of adults, 1971-1987. Am J Epidemiol 136:686-697
48. Pavlou KN, Krey S, Steffee WP 1989 Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr 49:1115-1123
49. Prentice AM, Jebb SA 1995 Obesity in Britain: gluttony or sloth? Br Med J 311:437-439
50. Ravussin E, Swinburn BA 1992 Pathophysiology of obesity. Lancet 340:404-408
51. Reed DR, Ding Y, Xu W, Cather C, Price RA 1995 Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borjeson or Wilson-Turner syndromes. Int J Obes 19:599-603
52. Rissanen A, Heliövaara M, Knekt P, Reunanen A, Aromaa A, Maatela J 1990 Risk of disability and mortality due to overweight in a Finnish population. Br Med J 301:835-837
53. Sobal J, Stunkard AJ 1989 Socioeconomic status and obesity: a review of the literature. Psychol Bull 105:260-275
54. Stamler R, Stamler J, Gosch FC, McDonald AM 1984 Primary prevention of hypertension: a randomized controlled trial. Ann Clin Res 43:136-142
55. Stamler J, Wentworth D, Neaton JD 1986 Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA 256:2823-2828
56. Stamler J, Neaton JD, Wentworth DN 1989 Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 13:21-121
57. Stuart RB 1967 Behavioral control of overeating. Behav Res Ther 5:357-365
58. Sugerman HJ, Kellum JM, Engle KM et al 1992 Gastric bypass for treating severe obesity. Am J Clin Nutr 55:560S-566S
59. Toeller M, Gries FA, Dannehl K 1982 Natural history of glucose tolerance in obesity. A ten year observation. Int J Obes 6:145-149
60. Trials of Hypertension Prevention Collaborative Research Group 1992 The effects of non-pharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention. JAMA 267:1213-1220
61. Vogler GP, Sorensen TIA, Stunkard AJ, Srinivasan MR, Rao DC 1995 Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obes 19:40-45
62. Waaler HT 1984 Height, weight and mortality: the Norwegian experience. Acta Med Scand 679:1-56
63. Wadden TA, Foster GD, Letizia KA, Mullen JL 1990 Long-term effects of dieting on resting metabolic rate in obese outpatients. JAMA 264:707-711
64. Walker BR, Ballard IM, Gold JA 1977 A multicentre study comparing mazindol and placebo in obese patients. J Int Med Res 5:85-90
65. Warden CH, Fisler JS, Shoemaker SM et al 1995 Identification of 4 chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest 95:1545-1552
66. Weintraub M, Sundaresan PR, Schuster B et al 1992 Long-term weight control: the National Heart, Lung and Blood Institute-funded multimodal intervention study. I-VII. Clin Pharmacol Ther 51:581-646
67. West DB, Goudey-Lefevre J, York B, Truett GE 1994 Dietary obesity linked to genetic-loci on chromosome-9 and chromosome-15 in a polygenic mouse model. J Clin Invest 94:1410-1416
68. Willett WC, Manson JE, Stampfer MJ et al 1995 Weight, weight change, and coronary heart disease in women: risk within the 'normal' weight range. JAMA 273:461-465
69. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C 1995 Prospective study of intentional weight-loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 141:1128-1141
70. Wood PD, Stefanick ML, Williams PT, Haskell WL 1991 Effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 325:461-466
71. DOH 1995 Obesity. Reversing the increasing problem of obesity in England. A report from the Nutrition and Physical Activity Task Forces (The Health of the Nation). Department of Health, London
72. Drent ML, Larsson I, William-Olson T et al 1995 Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes 19:221-226
73. Garrow JS 1992 The management of obesity. Another view. Int J Obes (suppl 2) 16:59S-63S
74. Garrow JS, Webster JD 1986 Long-term results of treatment of severe obesity with jaw wiring and waist cord. Proc Nutr Soc 45:119A
75. Goldstein DJ, Rampey AH Jr, Enas GG, Potvin JH, Fludzinski LA, Levine LR 1994 Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes 18:129-135
76. Green MW, Rogers PJ, Elliman NA, Gatenby SJ 1994 Impairment of cognitive performance associated with dieting and high levels of dietary restraint. Physiol Behav 55:447-452
77. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P 1989 International trial of long-term dexfenfluramine in obesity. Lancet II:1142-1144
78. Horton TJ, Drongas H, Brachey A, Reed GW, Peters JC, Hill JO 1995 Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr 62:19-29
79. Thomas PR 1995 Weighing the options: criteria for the evaluating weight-management programs. Food and Nutrition Board, Institute of Medicine, National Academy Press, Washington DC
80. Weintraub M, Sundaresan PR, Schuster B 1992 Long term weight control: the National Heart, Lung and Blood Institute-funded multimodal intervention study. I-VII. Clin Pharmacol Ther 51:581-646